As a company, Centinel Spine (Minneapolis) began operations in August 2008, through the merger-acquisition of two pioneering medical
device companies: Raymedica, LLC and Surgicraft LTD.
Founded in 1990, Raymedica became the recognized leader in nucleus replacement devices through the development of revolutionary products like the PDN® and HydraFlex®. Throughout its 18-year history, the company developed pioneering technologies and surgical approaches to the spine that helped thousands of patients restore function, reduce back pain, and avoid more invasive procedures. Raymedica was also the first company to develop a system for the Antero-Lateral Trans-Psoas Approach (ALPA)—implanting the PDN device via lateral access to the spine.
UK-based Surgicraft started spine-focused operations eight years earlier. In 1993, Surgicraft developed the revolutionary titanium Hartshill Horseshoe—the first stand-alone anterior lateral interbody fusion “STALIF®” device. Following 13 years of international clinical success, Surgicraft introduced the highly successful STALIF TT® to the US spine market in 2006—thereby creating the No-Profile, Integrated Interbody Device market. With superior biomechanics and design rationale, Surgicraft had an unparalleled clinical heritage in the Integrated Interbody space, spanning its entire 26-year history.
From the foundation of knowledge gained from the long-term clinical success of its lumbar products, Centinel launched its cervical product in 2009.
Products:
 |
| Stalif C |